Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 6, 2007
Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy
Stanley Franklin, Pablo Lapuerta, David Cox, et al.
Investigative Radiology
|
April 30, 2002
Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain
Val M Runge, John R Parker, Mark Donovan
Journal of Biopharmaceutical Statistics
|
May 27, 2006
Predicting event times in clinical trials when treatment arm is masked
J Mark Donovan, Michael R Elliott, Daniel F Heitjan
Clinical Trials (London, England)
|
October 19, 2007
Predicting event times in clinical trials when randomization is masked and blocked
J Mark Donovan, Michael R Elliott, Daniel F Heitjan
Experimental Dermatology
|
June 19, 2008
Heparanase 1: a key participant of inner root sheath differentiation program and hair follicle homeostasis
Sylvain Malgouries, Mark Donovan, Sébastien Thibaut, et al.
Pediatric Neurosurgery
|
January 31, 2002
Measurement of cerebrospinal fluid output through external ventricular drainage in one hundred infants and children: correlation with cerebrospinal fluid production
Takasumi Yasuda, Tadanori Tomita, David G McLone, et al.
Pharmaceutical Statistics
|
August 30, 2008
Use of simulation to compare the performance of minimization with stratified blocked randomization
Robert Toorawa, Michael Adena, Mark Donovan, et al.
Scientific Reports
|
October 5, 2018
Multivalent and multifunctional polysaccharide-based particles for controlled receptor recognition
Haohao Duan, Mark Donovan, Aude Foucher, et al.
Diabetes/Metabolism Research and Reviews
|
December 31, 2013
Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus
Boaz Hirshberg, Artist Parker, Helen Edelberg, et al.
Cardiovascular Diabetology
|
February 5, 2014
Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials
Nayyar Iqbal, Artist Parker, Robert Frederich, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 6, 2007
Initial combination therapy with irbesartan/hydrochlorothiazide for hypertension: an analysis of the relationship between baseline blood pressure and the need for combination therapy
Stanley Franklin, Pablo Lapuerta, David Cox, et al.
Investigative Radiology
|
April 30, 2002
Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain
Val M Runge, John R Parker, Mark Donovan
Journal of Biopharmaceutical Statistics
|
May 27, 2006
Predicting event times in clinical trials when treatment arm is masked
J Mark Donovan, Michael R Elliott, Daniel F Heitjan
Clinical Trials (London, England)
|
October 19, 2007
Predicting event times in clinical trials when randomization is masked and blocked
J Mark Donovan, Michael R Elliott, Daniel F Heitjan
Experimental Dermatology
|
June 19, 2008
Heparanase 1: a key participant of inner root sheath differentiation program and hair follicle homeostasis
Sylvain Malgouries, Mark Donovan, Sébastien Thibaut, et al.
Pediatric Neurosurgery
|
January 31, 2002
Measurement of cerebrospinal fluid output through external ventricular drainage in one hundred infants and children: correlation with cerebrospinal fluid production
Takasumi Yasuda, Tadanori Tomita, David G McLone, et al.
Pharmaceutical Statistics
|
August 30, 2008
Use of simulation to compare the performance of minimization with stratified blocked randomization
Robert Toorawa, Michael Adena, Mark Donovan, et al.
Scientific Reports
|
October 5, 2018
Multivalent and multifunctional polysaccharide-based particles for controlled receptor recognition
Haohao Duan, Mark Donovan, Aude Foucher, et al.
Diabetes/Metabolism Research and Reviews
|
December 31, 2013
Safety of saxagliptin: events of special interest in 9156 patients with type 2 diabetes mellitus
Boaz Hirshberg, Artist Parker, Helen Edelberg, et al.
Cardiovascular Diabetology
|
February 5, 2014
Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials
Nayyar Iqbal, Artist Parker, Robert Frederich, et al.
Page
of 4